Grossmann, Mathis <br/><br/>
Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.  [electronic resource] 

 -  The Medical journal of Australia  Mar 2011 
 - 301-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1326-5377 
<br/><br/><label>Standard No.: </label>10.5694/j.1326-5377.2011.tb02979.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Absorptiometry, Photon<br/>Aged<br/>Androgen Antagonists--adverse effects<br/>Antineoplastic Agents, Hormonal--adverse effects<br/>Bone Density--drug effects<br/>Combined Modality Therapy<br/>Diphosphonates--therapeutic use<br/>Exercise--physiology<br/>Humans<br/>Life Style<br/>Male<br/>Middle Aged<br/>Osteoporosis--chemically induced<br/>Osteoporotic Fractures--diagnosis<br/>Practice Guidelines as Topic<br/>Prognosis<br/>Prostatic Neoplasms--drug therapy<br/>Risk Assessment<br/>Treatment Outcome